Canada markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4700+0.0600 (+4.26%)
At close: 04:00PM EDT
1.4500 -0.02 (-1.36%)
After hours: 07:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 177.32M
Enterprise Value 97.79M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.21
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 2.01

Trading Information

Stock Price History

Beta (5Y Monthly) 1.20
52-Week Change 395.83%
S&P500 52-Week Change 332.30%
52 Week High 32.3100
52 Week Low 30.6200
50-Day Moving Average 31.3702
200-Day Moving Average 31.2800

Share Statistics

Avg Vol (3 month) 3670.18k
Avg Vol (10 day) 3605.6k
Shares Outstanding 5125.76M
Implied Shares Outstanding 6125.76M
Float 8117.92M
% Held by Insiders 10.06%
% Held by Institutions 127.46%
Shares Short (Sept 13, 2024) 413.18M
Short Ratio (Sept 13, 2024) 424.66
Short % of Float (Sept 13, 2024) 410.48%
Short % of Shares Outstanding (Sept 13, 2024) 410.48%
Shares Short (prior month Aug 15, 2024) 412.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 20, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 20, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.68%
Return on Equity (ttm)-28.00%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -30.55M
Net Income Avi to Common (ttm)-25.91M
Diluted EPS (ttm)-0.2100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)79.53M
Total Cash Per Share (mrq)0.63
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.35
Book Value Per Share (mrq)0.64

Cash Flow Statement

Operating Cash Flow (ttm)-18.68M
Levered Free Cash Flow (ttm)-10.24M